- Home
- GF vs NOTV Comparison
GF vs NOTV Comparison
Compare GF & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GF
- NOTV
- Stock Information
- Founded
- GF 1990
- NOTV 1974
- Country
- GF Germany
- NOTV United States
- Employees
- GF N/A
- NOTV N/A
- Industry
- GF Investment Managers
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- GF Finance
- NOTV Health Care
- Exchange
- GF Nasdaq
- NOTV Nasdaq
- Market Cap
- GF 167.2M
- NOTV 137.5M
- IPO Year
- GF N/A
- NOTV 1997
- Fundamental
- Price
- GF $10.07
- NOTV $2.15
- Analyst Decision
- GF
- NOTV Strong Buy
- Analyst Count
- GF 0
- NOTV 3
- Target Price
- GF N/A
- NOTV $5.92
- AVG Volume (30 Days)
- GF 28.1K
- NOTV 597.0K
- Earning Date
- GF 01-01-0001
- NOTV 05-09-2025
- Dividend Yield
- GF 0.82%
- NOTV N/A
- EPS Growth
- GF N/A
- NOTV N/A
- EPS
- GF N/A
- NOTV N/A
- Revenue
- GF N/A
- NOTV $475,114,000.00
- Revenue This Year
- GF N/A
- NOTV $6.37
- Revenue Next Year
- GF N/A
- NOTV $5.74
- P/E Ratio
- GF N/A
- NOTV N/A
- Revenue Growth
- GF N/A
- NOTV N/A
- 52 Week Low
- GF $7.38
- NOTV $1.23
- 52 Week High
- GF $9.41
- NOTV $11.20
- Technical
- Relative Strength Index (RSI)
- GF 57.31
- NOTV 34.04
- Support Level
- GF $10.14
- NOTV $2.72
- Resistance Level
- GF $10.28
- NOTV $3.35
- Average True Range (ATR)
- GF 0.14
- NOTV 0.32
- MACD
- GF -0.07
- NOTV -0.03
- Stochastic Oscillator
- GF 32.56
- NOTV 1.64
About GF New Germany Fund Inc. (The)
NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.